Literature DB >> 7378215

Comparison of vasodilator drug prazosin with digoxin in aortic regurgitation.

B E Hockings, G D Cope, G M Clarke, R R Taylor.   

Abstract

Intravenous administration of the vasodilator sodium nitroprusside has beneficial haemodynamic effects in subjects with severe aortic regurgitation while acute digitalisation can produce unwanted effects associated with an increase in systemic vascular resistance. This study compares the haemodynamic effects of the vasodilator prazosin and digoxin in eight patients with isolated severe aortic regurgitation. Prazosin 5 mg orally resulted in a 12 +/- 3 (SE) per cent increase in cardiac index (thermodilution), maintained over four to six hours, while digoxin 0.75 mg intravenously did not change the cardiac index. Prazosin reduced mean arterial pressure by 9 +/- 3 mmHg and systemic vascular resistance by 18 +/- 4 per cent while digoxin resulted in a 6 +/- 2 per cent increase in the latter. Mean pulmonary capillary wedge pressure fell 3 mmHg with prazosin. In this group of patients with severe aortic regurgitation but without severe cardiac failure, the changes with either drug, studied in doses conventionally used, were small but those with prazosin were directionally more desirable than those resulting from digoxin.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7378215      PMCID: PMC482340          DOI: 10.1136/hrt.43.5.550

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  16 in total

1.  Effects of prazosin on forearm resistance and capacitance vessels.

Authors:  N A Awan; R R Miller; K Maxwell; D T Mason
Journal:  Clin Pharmacol Ther       Date:  1977-07       Impact factor: 6.875

2.  Afterload reduction therapy with nitroprusside in severe aortic regurgitation: improved cardiac performance and reduced regurgitant volume.

Authors:  R R Miller; L A Vismara; A N DeMaria; A F Salel; D T Mason
Journal:  Am J Cardiol       Date:  1976-11-04       Impact factor: 2.778

3.  Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, hemodynamics and echocardiography.

Authors:  N A Awan; R R Miller; A N DeMaria; K S Maxwell; A Neumann; D T Mason
Journal:  Circulation       Date:  1977-09       Impact factor: 29.690

4.  Hemodynamics at rest and during exercise in combined aortic stenosis and insufficiency.

Authors:  P O Ettinger; M J Frank; G E Levinson
Journal:  Circulation       Date:  1972-02       Impact factor: 29.690

5.  Influence of various catecholamines on aortic regurgitation.

Authors:  B E Hopkins; R R Taylor
Journal:  J Appl Physiol       Date:  1973-03       Impact factor: 3.531

6.  Left ventricular end-diastolic pressure in chronic heart disease.

Authors:  C E Rackley; W P Hood; E L Rolett; D T Young
Journal:  Am J Med       Date:  1970-03       Impact factor: 4.965

7.  Pharmacodynamic studies in aortic regurgitation.

Authors:  F E Kloster; J D Bristow; R P Lewis; H E Griswold
Journal:  Am J Cardiol       Date:  1967-05       Impact factor: 2.778

8.  Direct determinations of aortic blood flow in patients with aortic regurgitation. Effects of alterations in heart rate, increased ventricular preload or afterload, and isoproterenol.

Authors:  R K Brawley; A G Morrow
Journal:  Circulation       Date:  1967-01       Impact factor: 29.690

9.  Hemodynamic consequences of afterload reduction in patients with chronic aortic regurgitation.

Authors:  J L Bolen; E L Alderman
Journal:  Circulation       Date:  1976-05       Impact factor: 29.690

10.  Digitalis-induced increase in aortic regurgitation and the contrasting effect of glucagon in the sedated dog.

Authors:  B E Hopkins; R R Taylor
Journal:  J Clin Invest       Date:  1974-06       Impact factor: 14.808

View more
  3 in total

1.  Captopril in congestive heart failure.

Authors:  G Liebau; A J Riegger; P Schanzenbächer; H Steilner; S Oehrlein
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

Review 2.  Are vasodilators still indicated in the treatment of severe aortic regurgitation?

Authors:  Jocelyn Inamo; Maurice Enriquez-Sarano
Journal:  Curr Cardiol Rep       Date:  2007-04       Impact factor: 2.931

Review 3.  Prazosin update. A review of its pharmacological properties and therapeutic use in hypertension and congestive heart failure.

Authors:  W F Stanaszek; D Kellerman; R N Brogden; J A Romankiewicz
Journal:  Drugs       Date:  1983-04       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.